Oncology News and Research

RSS
Roche to present data on its Herceptin, Avastin and T-DM1 studies at CTRC-AACR Symposium

Roche to present data on its Herceptin, Avastin and T-DM1 studies at CTRC-AACR Symposium

St. Luke's Hospital acquires computer-assisted surgery system from BrainLAB

St. Luke's Hospital acquires computer-assisted surgery system from BrainLAB

Spectrum Pharmaceuticals recognized as one of the Top Work Places in Orange County

Spectrum Pharmaceuticals recognized as one of the Top Work Places in Orange County

Joint Commission awards Primary Stroke Certification for TMCA

Joint Commission awards Primary Stroke Certification for TMCA

Clinical trial results demonstrate greater efficacy of nilotinib over imatinib for Ph+ CML

Clinical trial results demonstrate greater efficacy of nilotinib over imatinib for Ph+ CML

Particle Sciences expands High Potency Compound handling capabilities

Particle Sciences expands High Potency Compound handling capabilities

VERTICAL Phase II trial results for NHL released

VERTICAL Phase II trial results for NHL released

New drug designed to stop cancer from spreading by preventing mitosis

New drug designed to stop cancer from spreading by preventing mitosis

No co-pays for patients enrolled in AstraZeneca's Medicare Part D prescription savings program

No co-pays for patients enrolled in AstraZeneca's Medicare Part D prescription savings program

Human blood stem cells can be engineered to kill HIV and other chronic viral diseases

Human blood stem cells can be engineered to kill HIV and other chronic viral diseases

New Acesis software platform improves patient safety and quality care

New Acesis software platform improves patient safety and quality care

TGen and Scottsdale Healthcare test PHA-848125ac drug for thymic cancer

TGen and Scottsdale Healthcare test PHA-848125ac drug for thymic cancer

Mozobil with chemotherapy may have a therapeutic impact on leukemic cells, reveals study

Mozobil with chemotherapy may have a therapeutic impact on leukemic cells, reveals study

GSK updates long-term survival data of BEXXAR Therapeutic Regimen for Non-Hodgkin's lymphoma

GSK updates long-term survival data of BEXXAR Therapeutic Regimen for Non-Hodgkin's lymphoma

Transgenomic's SURVEYOR Scan K-RAS mutation detection kit launched

Transgenomic's SURVEYOR Scan K-RAS mutation detection kit launched

Multi-institutional study identifies potential treatment target for ovarian cancer

Multi-institutional study identifies potential treatment target for ovarian cancer

Neoprobe completes Phase 3 Lymphoseek clinical trial on breast cancer patients

Neoprobe completes Phase 3 Lymphoseek clinical trial on breast cancer patients

Pfizer, Crown Bioscience team up to research and develop novel therapeutics for Asian cancers

Pfizer, Crown Bioscience team up to research and develop novel therapeutics for Asian cancers

Epizyme closes Series B financing to a total of $40 million

Epizyme closes Series B financing to a total of $40 million

Veran Medical Technologies' SPiN Drive System receives FDA marketing clearance

Veran Medical Technologies' SPiN Drive System receives FDA marketing clearance

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.